AprilBio (397030) Financial Statements

Income Statement

YearRevenueOp ProfitNet IncomeSource
2025-7.3 billion KRW-9.7 billion KRW[source]
202416.9 billion KRW20.0 billion KRW[source]
2023-13.4 billion KRW-14.1 billion KRW[source]
2022-11.5 billion KRW-9.0 billion KRW[source]
20214.4 billion KRW-52.7 billion KRW

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202597.1 billion KRW804 million KRW96.3 billion KRW[source]
202499.6 billion KRW8.6 billion KRW91.0 billion KRW[source]
202379.7 billion KRW22.0 billion KRW57.7 billion KRW[source]
202271.1 billion KRW1.9 billion KRW69.2 billion KRW[source]
2021

This company has no revenue account in the DART financial statements. Industry-specific accounts such as insurance or interest income are not converted to revenue.

Years without a source link are outside the DART financial API collection period.